Back to 
NORGES BANK
NORGES BANK
PTGX
Showing 0 of 5 quarters
Position history for NORGES BANK's holdings in PROTAGONIST THERAPEUTICS INC
No. Norges Bank exited its PTGX (Protagonist Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 148,700 shares worth $1.6M. Norges Bank first reported PTGX in Q3 2020 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.